Krsnaa Diagnostics [KRSNAA] vs Indoco Remedies [INDOCO] Detailed Stock Comparison

Krsnaa Diagnostics

NSE
Loading...

Indoco Remedies

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Krsnaa Diagnostics wins in 12 metrics, Indoco Remedies wins in 7 metrics, with 0 ties. Krsnaa Diagnostics appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricKrsnaa DiagnosticsIndoco RemediesBetter
P/E Ratio (TTM)34.77101.34Krsnaa Diagnostics
Price-to-Book Ratio3.092.41Indoco Remedies
Debt-to-Equity Ratio23.0697.56Krsnaa Diagnostics
PEG Ratio2.41-0.05Indoco Remedies
EV/EBITDA13.9942.93Krsnaa Diagnostics
Profit Margin (TTM)10.84%-6.71%Krsnaa Diagnostics
Operating Margin (TTM)15.42%-2.78%Krsnaa Diagnostics
EBITDA Margin (TTM)15.42%N/AN/A
Return on Equity8.79%-7.24%Krsnaa Diagnostics
Return on Assets (TTM)6.06%-3.03%Krsnaa Diagnostics
Free Cash Flow (TTM)$-393.00M$-1.68BKrsnaa Diagnostics
Dividend Yield0.36%0.60%Indoco Remedies
1-Year Return4.47%-25.53%Krsnaa Diagnostics
Price-to-Sales Ratio (TTM)3.711.51Indoco Remedies
Enterprise Value$28.54B$34.58BIndoco Remedies
EV/Revenue Ratio3.862.07Indoco Remedies
Gross Profit Margin (TTM)67.46%68.54%Indoco Remedies
Revenue per Share (TTM)$229$217Krsnaa Diagnostics
Earnings per Share (Diluted)$24.32$-12.15Krsnaa Diagnostics
Beta (Stock Volatility)-0.160.43Krsnaa Diagnostics
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Krsnaa Diagnostics vs Indoco Remedies Stock Performance Analysis

Loading Price Chart...

Krsnaa Diagnostics
Indoco Remedies
Krsnaa Diagnostics Stock Overview | Indoco Remedies Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Krsnaa Diagnostics1.45%5.92%-3.05%22.42%14.61%-7.71%
Indoco Remedies-0.11%0.36%-2.67%-5.19%19.91%-16.71%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Krsnaa Diagnostics4.47%69.72%-9.31%-9.31%-9.31%-9.31%
Indoco Remedies-25.53%-22.49%2.54%-17.22%381.80%515.71%

News Based Sentiment: Krsnaa Diagnostics vs Indoco Remedies

Krsnaa Diagnostics

News based Sentiment: POSITIVE

Krsnaa Diagnostics delivered strong Q1 FY2025-26 results, announced a dividend increase, and is aggressively expanding its PPP and retail networks. Positive analyst coverage and institutional interest further support a bullish outlook, making this a significant month for the company's investment story.

View Krsnaa Diagnostics News Sentiment Analysis

Indoco Remedies

News based Sentiment: MIXED

Indoco Remedies is showing some positive signs with revenue growth and USFDA approval, but continues to struggle with significant net losses and faces ongoing regulatory hurdles. The mixed analyst sentiment and insider activity create a complex investment picture, making this a moderately important month for the company's trajectory.

View Indoco Remedies News Sentiment Analysis

Performance & Financial Health Analysis: Krsnaa Diagnostics vs Indoco Remedies

MetricKRSNAAINDOCO
Market Information
Market Cap i₹27.31B₹25.32B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i55,69524,586
90 Day Avg. Volume i63,25141,612
Last Close₹840.60₹276.70
52 Week Range₹625.75 - ₹1,044.00₹190.00 - ₹385.75
% from 52W High-19.48%-28.27%
All-Time High₹1,099.70 (Aug 16, 2021)₹530.25 (Aug 09, 2021)
% from All-Time High-23.56%-47.82%
Growth Metrics
Quarterly Revenue Growth0.13%0.02%
Quarterly Earnings Growth0.15%0.01%
Financial Health
Profit Margin (TTM) i0.11%-0.07%
Operating Margin (TTM) i0.15%-0.03%
Return on Equity (TTM) i0.09%-0.07%
Debt to Equity (MRQ) i23.0697.56
Cash & Liquidity
Book Value per Share (MRQ)₹273.22₹113.36
Cash per Share (MRQ)₹21.18₹1.88
Operating Cash Flow (TTM) i₹2.45M₹-160,900,000
Levered Free Cash Flow (TTM) i₹776.08M₹-737,400,000
Dividends
Last 12-Month Dividend Yield i0.36%0.60%
Last 12-Month Dividend i₹2.50₹1.70

Valuation & Enterprise Metrics Analysis: Krsnaa Diagnostics vs Indoco Remedies

MetricKRSNAAINDOCO
Price Ratios
P/E Ratio (TTM) i34.77101.34
Forward P/E i20.9620.37
PEG Ratio i2.41-0.05
Price to Sales (TTM) i3.711.51
Price to Book (MRQ) i3.092.41
Market Capitalization
Market Capitalization i₹27.31B₹25.32B
Enterprise Value i₹28.54B₹34.58B
Enterprise Value Metrics
Enterprise to Revenue i3.862.07
Enterprise to EBITDA i13.9942.93
Risk & Other Metrics
Beta i-0.160.43
Book Value per Share (MRQ) i₹273.22₹113.36

Financial Statements Comparison: Krsnaa Diagnostics vs Indoco Remedies

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)KRSNAAINDOCO
Revenue/Sales i₹1.86B₹3.84B
Cost of Goods Sold i₹589.52M₹1.06B
Gross Profit i₹1.27B₹2.78B
Research & Development iN/A₹173.90M
Operating Income (EBIT) i₹310.28M₹-295.60M
EBITDA i₹573.71M₹12.40M
Pre-Tax Income i₹286.03M₹-455.20M
Income Tax i₹79.27M₹-41.80M
Net Income (Profit) i₹206.76M₹-413.40M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)KRSNAAINDOCO
Cash & Equivalents i₹38.45M₹121.00M
Total Current Assets i₹4.14B₹10.01B
Total Current Liabilities i₹3.05B₹8.08B
Long-Term Debt i₹471.56M₹5.43B
Total Shareholders Equity i₹8.83B₹10.18B
Retained Earnings iN/AN/A
Property, Plant & Equipment i₹6.67B₹8.49B

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)KRSNAAINDOCO
Operating Cash Flow iN/AN/A
Capital Expenditures iN/AN/A
Free Cash Flow iN/AN/A
Debt Repayment iN/AN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricKRSNAAINDOCO
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Average Daily Volume (10 Day) i55,69524,586
Average Daily Volume (90 Day) i63,25141,612
Shares Outstanding i32.29M92.16M
Float Shares i17.39M34.30M
% Held by Insiders i0.44%0.61%
% Held by Institutions i0.15%0.19%

Dividend Analysis & Yield Comparison: Krsnaa Diagnostics vs Indoco Remedies

MetricKRSNAAINDOCO
Last 12-Month Dividend i₹2.50₹1.70
Last 12-Month Dividend Yield i0.36%0.60%
3-Year Avg Annual Dividend i₹2.58₹1.82
3-Year Avg Dividend Yield i0.40%0.39%
3-Year Total Dividends i₹7.75₹5.45
Ex-Dividend DateSep 13, 2024Sep 04, 2025